Pioneering amfAR-Funded Study Underway

A potentially groundbreaking clinical trial will test a combination HIV cure strategy.

• Molecular Pathways to an HIV Cure
• New Study Takes Deep Dive into Elite Control
• Launching an HIV Trial in the Time of COVID-19
• A Tale of Two Viruses: HIV Researcher Joins Fight Against COVID-19

amfAR Study Shows How White Counties Have Lower Rates of COVID-19, HIV

Study shows that primarily white counties in the U.S. have the fewest cases of COVID-19 irrespective of geographic region, political inclination or before/after re-opening the economy.

• amfAR Study Shows Disproportionate Impact of COVID-19 on Black Americans
• Victory for AIDS Activists over Vaccine Trial Exclusion
• Context Matters - Health Insurance Coverage Is Fundamental to Ending the HIV Epidemic

ISSUE BRIEF: Violence Crisis Services During Lockdown

amfAR assesses GBV service availability during COVID-19 lockdown in South Africa.

• Global Anti-HIV Drug Supplies Running Low
• COVID-19 Pandemic Threatens HIV Drug Supplies
• Former TREAT Asia Student Researcher Named Student Who Rocked Public Health

Victory for AIDS Activists over Vaccine Trial Exclusion

After pressure from advocates, people with HIV are no longer barred from COVID-19 vaccine trial.

COVID-19 and HIV/AIDS

We are constantly gathering new information to keep you up to date on the intersection between HIV and COVID-19. The hard-won lessons of HIV research are informing the race to find effective treatments and a vaccine for COVID-19.

Intersections #8: HIV and COVID-19 – DNA Vaccine

amfAR-funded HIV researcher Dr. Dan Barouch of Harvard Medical School talks to amfAR’s Dr. Rowena Johnston about his team’s efforts to rapidly develop a safe and effective vaccine against the coronavirus.